This finding suggests the AS of regulatory factors can help rectify the differential expression of VEGF pro- and anti-angiogenic isoforms, potentially inhibiting tumour angiogenesis and improving the efficacy of anti-cancer treatments. The gene discussed is VEGFA; the disease is cancer.